Clinical Trials on Severe Covid-19 in Korea, Republic of
Total 461 results
-
Daewoong Pharmaceutical Co. LTD.TerminatedSevere COVID-19Korea, Republic of
-
Asan Medical CenterSuspendedCoronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Mild to Moderate COVID-19Korea, Republic of
-
LemonexRecruitingCOVID-19 Infection | COVID-19 Vaccine Adverse ReactionKorea, Republic of
-
Jaehoon KoRecruitingCOVID-19Korea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingCOVID-19 PneumoniaKorea, Republic of
-
Seoul National University HospitalRecruitingRenal Transplant | COVID-19 VaccinationKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.TerminatedMild to Moderate COVID-19Korea, Republic of
-
University of Illinois at Urbana-ChampaignCompletedPhysical Function | Cardiovascular HealthKorea, Republic of
-
Korea University Guro HospitalRecruitingCovid-19 | SARS-CoV-2 | Vaccine | Microbiome | ImmunogenicityKorea, Republic of
-
Gangnam Severance HospitalWithdrawnContact Person From COVID-19 Confirmed PatientKorea, Republic of
-
Shahid Beheshti University of Medical SciencesUnknownCOVID | SARS (Severe Acute Respiratory Syndrome)Iran, Islamic Republic of
-
ShaperonRecruiting
-
Daewoong Pharmaceutical Co. LTD.TerminatedCOVID-19 PatientsKorea, Republic of
-
SK Bioscience Co., Ltd.CompletedCOVID-19 (Healthy Volunteers)Korea, Republic of
-
LG Life SciencesUnknownNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar RegionKorea, Republic of
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
Korea University Guro HospitalAjou University School of Medicine; Korean Center for Disease Control and Prevention and other collaboratorsRecruitingInflammation | Vaccine Adverse Reaction | Vaccine Immune Response | COVID-19 VaccinationKorea, Republic of
-
AMIpharm Co., Ltd.CompletedModerate or Severe Submental FullnessKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
LG Life SciencesCompletedNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 StudyKorea, Republic of
-
Korea University Guro HospitalKorean Center for Disease Control and PreventionActive, not recruitingCOVID-19 (Healthy Volunteers)Korea, Republic of
-
Bukwang PharmaceuticalCompletedCOVID-19Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
U.S. Army Medical Research and Development CommandEnrolling by invitationHemorrhagic Fever With Renal SyndromeKorea, Republic of
-
SK Bioscience Co., Ltd.Coalition for Epidemic Preparedness InnovationsCompletedCOVID-19 (Healthy Volunteers)Korea, Republic of
-
Yonsei UniversityCompletedSevere Sepsis or Septic ShockKorea, Republic of
-
Green Cross CorporationCompleted
-
EuBiologics Co.,LtdCompletedSafety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy AdultsCOVID-19Korea, Republic of
-
Korea University Guro HospitalCompleted
-
Asan Medical CenterTerminatedCOVID-19Korea, Republic of
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Seoul National University HospitalDong-A ST Co., Ltd.Not yet recruiting
-
Jaseng Hospital of Korean MedicineCompleted
-
Quratis Inc.Active, not recruitingCOVID-19 | SARS-CoV-2Korea, Republic of
-
Kyungpook National University HospitalRecruiting
-
Genexine, Inc.Terminated
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Seoul National University HospitalCompletedCancer | Covid19Korea, Republic of
-
AMIpharm Co., Ltd.CompletedModerate or Severe Submental FullnessKorea, Republic of
-
CelltrionCompletedSARS-CoV-2 InfectionKorea, Republic of
-
CelltrionCompletedSARS-CoV-2 InfectionKorea, Republic of
-
Genencell Co. Ltd.Recruiting
-
SK Bioscience Co., Ltd.GlaxoSmithKline; Coalition for Epidemic Preparedness InnovationsActive, not recruitingCOVID-19 (Healthy Volunteers)Korea, Republic of
-
ImmuneMed, Inc.Terminated
-
Enzychem Lifesciences CorporationCompletedCOVID-19Korea, Republic of
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2 | Adverse Effects | Safety | VaccinesKorea, Republic of
-
Cellid Co., Ltd.International Vaccine InstituteTerminated
-
Seoul National University Bundang HospitalCompleted
-
HK inno.N CorporationRecruitingCOVID-19Korea, Republic of
-
Seoul National University HospitalActive, not recruitingCOVID-19 PneumoniaKorea, Republic of